EXHIBIT 32.1


                             Certification
                  Pursuant to 18 U.S.C. Section 1350,
                              As Adopted
                    Pursuant to Section 906 of the
                               Sarbanes -
                          Oxley Act of 2002

In connection with the quarterly  report of China  Biopharmaceuticals  Holdings,
Inc. (the "Company"), on Form 10-QSB for the quarter ended September 30, 2004 as
filed with the  Securities  and Exchange  Commission  ("SEC") on the date hereof
(the "Report"), the undersigned officer of the Company certifies, pursuant to 18
U.S.C.  ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of his knowledge:

         i. the Report fully complies with the  requirements  of Section 13(a)or
15(d) of the Securities Exchange Act of 1934; and

         ii. the  information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

A signed original of this written statement has been provided to the Company and
will be retained by the  Company and will be  furnished  to the SEC or its staff
upon request.

 /s/ MAO Peng
- ------------------------------------
MAO Peng
Chairman and Chief Executive Officer
February 4, 2005

This  Certification  of Chief Executive  Officer  pursuant to Section 906 of the
Sarbanes-Oxley  Act of 2002 is not  "filed"  for  purposes  of Section 18 of the
Securities  Exchange  Act of  1934  but is  instead  furnished  as  provided  by
applicable rules of the Securities Exchange Commission.